Shanghai Applied Protein Technology Co.
Latest round
- Series C
Last raised
- Apr 2024
Total raised
- $28M
Investors
- 5
About Shanghai Applied Protein Technology Co.
, and formerly known as the Proteome Research and Analysis Center (SIBS) of Shanghai Institutes for Biological Sciences, CAS. It was one of the first platforms to participate in international HLPP (liver) and HPPP (plasma) projects, and has obtained CMA metrology certification and Dun & Bradstreet certification. The company has also published hundreds of papers in SCI journals and obtained dozens of invention patents and copyrights. In the field of mass spectrometry multi-omics precision medical applications, the company has established three service platforms for scientific and technical services (protein/modification/metabolism research), biomedical characterization and confirmation, and precision medicine. Through these platforms, the company provides services such as high-throughput sequencing - genome sequencing, proteome - quantitative proteome iTRAQ (isobaric tags for relative and absolute quantitation, an in vitro peptide labeling technology), Single cell sequencing, etc. The company’s revenue is generated by providing three major service platforms: scientific and technological services (protein/modification/metabolism research), biomedical characterization and verification, and precision medicine.
Who invested in Shanghai Applied Protein Technology Co.
5 investors across 3 rounds
See all investors in Shanghai Applied Protein Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shanghai Applied Protein Technology Co.
Who invested in Shanghai Applied Protein Technology Co.?
Shanghai Applied Protein Technology Co. has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shanghai Applied Protein Technology Co. raised?
Shanghai Applied Protein Technology Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Shanghai Applied Protein Technology Co. last raise money?
Shanghai Applied Protein Technology Co.'s most recent round on record is a Series C, in Apr 2024.
What does Shanghai Applied Protein Technology Co. do?
, and formerly known as the Proteome Research and Analysis Center (SIBS) of Shanghai Institutes for Biological Sciences, CAS.
Where is Shanghai Applied Protein Technology Co. headquartered?
Shanghai Applied Protein Technology Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Shanghai Applied Protein Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Shanghai Applied Protein Technology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Shanghai Applied Protein Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.